Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 360,038 | 0 | 0 | N/A | 0 |
| Marketable Securities | 26,761 | 0 | 0 | N/A | 0 |
| TOTAL | $393,778 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 146 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 9,508 | 0 | 0 | 0 | 0 |
| TOTAL | $9,654 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $403,432 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,082 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 28,531 | 0 | 0 | N/A | 0 |
| TOTAL | $43,997 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $43,997 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,791 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | 0 | 0 | N/A | 0 |
| Retained earnings | -334,786 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 54 | 0 | 0 | 0 | 0 |
| TOTAL | $359,435 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $403,432 | $0 | $0 | $0 | $0 |